Welcome Notes

Dear Esteemed Attendees, Researchers, and Visionaries,

With immense enthusiasm and pride, we invite you to join us at the “29th International Conference on Diabetes, Endocrinology, and Healthcare”, where innovation meets collaboration in the vibrant city of “Dubai, UAE”, on “January 27-28, 2025”.

This prestigious event unites leading experts, trailblazing researchers, and healthcare pioneers from around the world to advance our understanding of diabetes and endocrinology. Over two days, we will explore groundbreaking research, emerging treatments, and holistic healthcare approaches aimed at transforming patient outcomes and revolutionizing care.

Be prepared to immerse yourself in engaging keynote presentations, dynamic panel discussions, and interactive sessions designed to inspire and inform. This conference serves as a global stage for sharing insights, fostering partnerships, and sparking new ideas that will define the future of diabetes care and endocrine health.

We encourage you to take full advantage of this unique opportunity to connect with like-minded professionals, exchange knowledge, and collaborate on solutions to the most pressing challenges in the field. Your participation is what makes this gathering a hub of innovation and progress.

About Diabetes, Endocrinology and Healthcare

The “29th International Conference on Diabetes, Endocrinology, and Healthcare”, taking place on “January 27-28, 2025”, in “Dubai, UAE”, will serve as a premier platform to explore the theme: "Advancing Global Perspectives in Diabetes and Endocrinology through Innovation and Collaboration."

This prestigious event will bring together leading researchers, healthcare professionals, policymakers, and students from around the world to discuss the latest breakthroughs in diabetes care, endocrinology, and healthcare innovations. The conference will build upon the success of previous gatherings, providing a forum to:

• Examine the global impact of diabetes and endocrinology disorders, focusing on innovative treatments and emerging research.
• Discuss how healthcare systems worldwide are adapting to post-pandemic challenges in diabetes care, including insights on prevention, remission, and advanced treatment options.
• Highlight cutting-edge technologies such as AI, telemedicine, and personalized medicine that are reshaping the delivery of endocrine and diabetes care.

Participants will have the unique opportunity to engage with distinguished speakers, collaborate with like-minded professionals, and gain critical knowledge about key topics, including:

• The latest strategies for Type 2 diabetes management and remission.
• Advances in secondary care and solutions for addressing complications in diabetes.
• Insights into hormonal therapies and breakthroughs in endocrinology.

With diabetes expected to impact over 201.8 million people in Asia by 2035, this conference underscores the urgency of advancing prevention, treatment, and education. Join us to make meaningful contributions to the future of diabetes and endocrine healthcare and to drive innovation that improves lives.

Session & Tracks

Track 1: Endocrine and Disorders
Track 2: Types of Diabetes
Track 3: Diabetes Mellitus
Track 4: Diabetes Symptoms and Complications
Track 5: Obesity and Metabolism for Diabetes
Track 6: Diabetic Retinopathy
Track 7: Diabetic Nephropathy
Track 8: Diabetic Nutrition and Diet
Track 9: Diabetes Etiology
Track 10: Diabetes: Advanced Technologies and Treatments
Track 11: Blood Glucose Dynamics and Monitoring
Track 12: Emerging Treatments and Technologies
Track 13: Nanotechnology in Diabetes Treatment
Track 14: Prediabetes to Late-Stage Complicated Diabetes
Track 15: Clinical Care and Education
Track 16: COVID-19 and Diabetes, Post-COVID Diabetes
Track 17: Diabetes and Cardiology
Track 18: Risks and Benefits of New Therapies
Track 19: Transplantation and Artificial Pancreas
Track 20: Insulin Resistance & Insulin therapy
Track 21: Mental Health and Diabetes
Track 22: Artificial Intelligence: The Future for Diabetes Care

Target Audience

•  Endocrinologists 
•  Diabetologists 
•  Gynaecologist Neurologists
•  Ophthalmologists
•   Oncologists
•   Physicians
•   Nutritionists/Dieticians
•   Diabetes Health Professionals
•   Medical faculties
•   Academic researchers
•   Research Institutes
•   Endocrinology Societies & Associations
•   Diabetes Societies & Associations
•   Obesity Societies & Associations
•   Pharmaceutical corporations
•   Researchers
•   Endocrinology, polygenic disorder & Metabolism Associations and Societies |
•   Business Entrepreneurs
•   Training Institutes
•    Manufacturing Medical Devices corporations 

Benefits of Attending

• Global Networking Opportunities
• Collaborative Approaches to Innovation
• Access to Expertise
• Comprehensive Knowledge Exchange
• Problem-Solving and Strategic Dialogues
• Professional Development
• Collaborative Learning Environment
• Access to Multidisciplinary Perspectives
• Workshops and Practical Applications
• Stay Ahead of Industry Trends
• Contribute to Global Healthcare Goals
• Platform for Presenting Your Work
• Inspiration and Motivation

Attending this conference ensures a well-rounded experience that combines professional growth, innovative learning, and opportunities to create meaningful contributions to the field of diabetes and endocrinology.

Market Overview

Global Diabetes Market Overview

The global diabetes market is anticipated to grow at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2018–2023. This market is categorized by diabetes type, drug class, and diabetic devices. Among diabetic devices, blood glucose meters hold the largest market share, outperforming insulin delivery systems such as syringes and pen injectors.

The segment of continuous glucose monitoring systems (CGMS) is expected to witness the fastest growth, fuelled by increased adoption and technological advancements. The United States allocates approximately 11% of its healthcare expenditures to diabetes management. Meanwhile, India and China remain the most affected regions, with over 120 million diabetes patients, a significant proportion of whom are undiagnosed or lack access to basic treatment options.

Major market players are striving to develop advanced solutions such as the artificial pancreas, which is currently in prototype stages using CGMS devices combined with insulin pumps. Commercialization of the artificial pancreas is projected within the next decade, revolutionizing diabetes care. Read More .

Past Conference

The 28th International Conference on Diabetes, Endocrinology, and Healthcare was successfully held in Dubai, UAE, on November 21-22, 2024, under the theme "Innovation in Diabetes, Cutting-edge Technologies, and the Latest Research." This event brought together a distinguished group of global researchers, healthcare professionals, and industry leaders to discuss the most recent advancements and challenges in the field.

Highlights of the 2024 Conference

Renowned Keynote Speakers:
The conference featured influential keynote addresses by:

·         Dr. Michael Turner (USA), an authority on diabetes technologies and artificial pancreas systems.

·         Prof. Ayesha Khan (UK), specializing in endocrinology and diabetes-related complications.

·         Dr. Rahul Mehta (India), a leader in Type 2 diabetes prevention and remission strategies.

Scientific Tracks and Sessions:
Over 40 specialized sessions explored diverse topics, including:

·         Advances in diabetes diagnostics and treatment.

·         Innovations in endocrinology and metabolic disorders.

·         Impact of COVID-19 on Type 2 diabetes care.

·         Latest breakthroughs in CGMS and insulin delivery systems.

·         Emerging trends in personalized diabetes management and telemedicine.

Young Researcher Forum:
The event provided an excellent platform for emerging scientists to showcase their work. Highlights included groundbreaking studies on biomarkers for early detection of diabetes complications and AI-powered tools for endocrinology research.

Networking and Collaborations:
The conference welcomed attendees from over 45 countries, fostering meaningful discussions and interdisciplinary collaborations between academia, industry, and clinical sectors.

Workshops and Interactive Sessions:
Practical workshops on:

·         Real-world applications of digital diabetes tools.

·         Integration of AI and machine learning in endocrinology.

·         Strategies for effective diabetes care in low-resource settings.

Notable Achievements

·         Facilitated numerous global partnerships to advance diabetes research and care.

·         Generated significant interest in emerging technologies such as artificial pancreas systems and digital diabetes management platforms.

·         Provided actionable insights for healthcare professionals on improving patient outcomes.

Feedback and Future Goals

The success of the 28th conference has created high expectations for the 29th International Conference on Diabetes, Endocrinology, and Healthcare, scheduled for January 27-28, 2025, in Dubai, UAE.

Building on the success of the previous conference, the upcoming event aims to:

·         Expand the scope to include areas such as regenerative medicine and bioinformatics.

·         Encourage wider global participation, with a focus on emerging markets and developing countries.

·         Showcase pioneering research and provide a robust platform for meaningful collaborations across disciplines.

The 28th International Conference highlighted the transformative power of innovation, collaboration, and dedication in tackling global diabetes and endocrinology challenges. We look forward to continuing this legacy in 2025.

Important Guidelines:

Abstract submission deadline: Jan 10, 2025

First Phase Registration: Sept 28, 2024

Early Bird Registration Deadline: Sept 28, 2024

Book your slot: HERBAL DIABETES 2025

Email: Program Manager at herbaldiabetes@meetingsnexpo.com

WhatsApp at 447915641825 with details of the 5 participants.

Abstract submission guidelines for Herbal Diabetes 2025.
If you choose to participate in this conference, you need to submit an abstract.
The abstract should carry the summary of a research.
Abstract should be submitted either through e-mail or using the link given below.
Abstracts should be based on any areas as listed in this website as sessions/tracks.

Note: The review process for the submitted abstract will take 2-3 working days.

Submitting abstract will be published in conference proceedings in the conference supporting journal

Abstract Submission website: HERBAL DIABETES  ABSTRACT SUBMISSION
Contact us:
Event Manager| HERBAL DIABETES 2025
Email Id:  herbaldiabetes@meetingsnexpo.com